Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Charles River Laboratories International Inc, Medical Devices Deals, 2011 to YTD 2017 11
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deal Details 16
Asset Purchase 16
WIL Research Acquires Pharma Services Business Of Ricerca Biosciences 16
Partnerships 18
Inscopix Enters into Partnership with Brains On-Line 18
Nimbus Therapeutics Enters into Agreement with Charles River Laboratories International 19
Charles River Laboratories International Expands its Agreement with Chiesi Farmaceutici 20
Charles River Laboratories International Extends Agreement with Genentech 21
Charles River Labs Enters into Agreement with Tri-Institutional Therapeutics Discovery Institute 22
Moderna Therapeutics Enters into Agreement with Charles River Labs 23
Charles River Labs Enters into Agreement with BioMotiv 24
Eisai Extends Research Agreement with Charles River Labs 25
Charles River Labs Expands its Agreement with Michael J. Fox Foundation for Parkinson’s Research 26
Charles River Labs Enters into Agreement with Antabio 27
Charles River Labs Enters into Agreement with Pcovery 28
Charles River Labs Enters into Agreement with British Columbia Cancer Agency 29
Charles River Lab Extends Co-Development Agreement with CHDI Foundation 30
BioFocus Enters Into Drug Discovery Agreement With Boehringer Ingelheim 31
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson’s Disease 32
Applied StemCell Enters Into Distribution Agreement With Charles River Labs For Genetically Modified Targatt Mouse 33
BioFocus Enters Into Agreement With ChanTest 34
Charles River Labs Expands its Agreement with AstraZeneca 35
Ono Pharma Enters Into Discovery Agreement With BioFocus For CNS Drugs 36
Activiomics Enters Into Drug Discovery Agreement With BioFocus 37
Ono Pharma Enters Into Drug Discovery Agreement With BioFocus 38
Almirall Enters Into Integrated Drug Discovery Collaboration With BioFocus 39
Protagen Enters Into Co-Marketing Agreement With Charles River Labs 40
BioFocus Enters Into Co-Marketing Agreement With InterMed Discovery 41
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson’s Disease 42
BioFocus Extends Its Collaboration With Usher III Initiative 43
BioFocus Enters Into Co-Development Agreement With Astellas Pharma 44
BioFocus Enters Into An Agreement With Almac Group 45
ChanTest Corporation Enters Into Co-Marketing Agreement With Molecular Devices 46
Charles River Labs Enters Into Distribution Agreement With Pfizer 47
Ono Pharma Enters Into Co-Development Agreement With BioFocus 48
Licensing Agreements 49
EMD Millipore Enters Into Licensing Agreement With Charles River Labs For TrueSpike Technology 49
Equity Offering 50
Charles River Labs to Invest USD10 Million in BioMotiv 50
Asset Transactions 51
Charles River Labs International Sells Preclinical Assets 51
ShangPharma Acquires Shanghai In-vivo Drug Research Facility From Charles River Labs 52
Acquisition 53
Charles River Laboratories Acquires Brains On-Line 53
Quotient Clinical Acquires QS Pharma from Charles River Labs 54
Charles River Laboratories Acquires Agilux Laboratories for USD64.9 Million 55
Charles River Labs Acquires Blue Stream Labs 56
Charles River Laboratories Acquires WIL Research for USD604.8 Million 57
Charles River Labs Acquires Oncotest 59
Charles River Labs Acquires ChanTest from Ampersand Capital for USD59.2 Million 60
Charles River Labs Completes Acquisition Of BioFocus And Argenta Discovery From Galapagos For USD191.8 Million 61
Charles River Labs Acquires Brass 63
Charles River Labs Completes Acquisition Of 75% Stake In Vital River Labs For US$27 Million 64
Charles River Plans Sale Of The Company 65
Charles River Laboratories International Inc – Key Competitors 66
Charles River Laboratories International Inc – Key Employees 67
Charles River Laboratories International Inc – Locations And Subsidiaries 69
Head Office 69
Other Locations & Subsidiaries 69
Recent Developments 72
Financial Announcements 72
Nov 09, 2017: Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing Operations 72
Aug 09, 2017: Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing Operations 74
May 10, 2017: Charles River Laboratories Announces First-Quarter 2017 Results from Continuing Operations 76
Feb 14, 2017: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 Guidance 78
Nov 02, 2016: Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing Operations 81
Aug 03, 2016: Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing Operations 83
May 04, 2016: Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations 85
Feb 10, 2016: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance 87
Corporate Communications 90
Jul 05, 2017: Charles River Laboratories Adds Martin Mackay, Ph.D. to Board of Directors 90
Product News 91
Apr 03, 2017: Charles River Laboratories Announces Launch of Triple-Immunodeficient Mouse Model for Oncology Research 91
Other Significant Developments 92
Dec 06, 2017: Charles River Adds ERS License to CRISPR/Cas9 Service Offering 92
May 16, 2017: Charles River Laboratories Announces Updates to Oncology Business 93
Dec 01, 2016: Charles River Laboratories Demonstrates Expertise in CRISPR/Cas9 Genome Engineering Technology 94
Appendix 95
Methodology 95
About GlobalData 95
Contact Us 95
Disclaimer 95
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Charles River Laboratories International Inc, Deals By Therapy Area, 2011 to YTD 2017 10
Charles River Laboratories International Inc, Medical Devices Deals, 2011 to YTD 2017 11
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
WIL Research Acquires Pharma Services Business Of Ricerca Biosciences 16
Inscopix Enters into Partnership with Brains On-Line 18
Nimbus Therapeutics Enters into Agreement with Charles River Laboratories International 19
Charles River Laboratories International Expands its Agreement with Chiesi Farmaceutici 20
Charles River Laboratories International Extends Agreement with Genentech 21
Charles River Labs Enters into Agreement with Tri-Institutional Therapeutics Discovery Institute 22
Moderna Therapeutics Enters into Agreement with Charles River Labs 23
Charles River Labs Enters into Agreement with BioMotiv 24
Eisai Extends Research Agreement with Charles River Labs 25
Charles River Labs Expands its Agreement with Michael J. Fox Foundation for Parkinson’s Research 26
Charles River Labs Enters into Agreement with Antabio 27
Charles River Labs Enters into Agreement with Pcovery 28
Charles River Labs Enters into Agreement with British Columbia Cancer Agency 29
Charles River Lab Extends Co-Development Agreement with CHDI Foundation 30
BioFocus Enters Into Drug Discovery Agreement With Boehringer Ingelheim 31
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 32
Applied StemCell Enters Into Distribution Agreement With Charles River Labs For Genetically Modified Targatt Mouse 33
BioFocus Enters Into Agreement With ChanTest 34
Charles River Labs Expands its Agreement with AstraZeneca 35
Ono Pharma Enters Into Discovery Agreement With BioFocus For CNS Drugs 36
Activiomics Enters Into Drug Discovery Agreement With BioFocus 37
Ono Pharma Enters Into Drug Discovery Agreement With BioFocus 38
Almirall Enters Into Integrated Drug Discovery Collaboration With BioFocus 39
Protagen Enters Into Co-Marketing Agreement With Charles River Labs 40
BioFocus Enters Into Co-Marketing Agreement With InterMed Discovery 41
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson's Disease 42
BioFocus Extends Its Collaboration With Usher III Initiative 43
BioFocus Enters Into Co-Development Agreement With Astellas Pharma 44
BioFocus Enters Into An Agreement With Almac Group 45
ChanTest Corporation Enters Into Co-Marketing Agreement With Molecular Devices 46
Charles River Labs Enters Into Distribution Agreement With Pfizer 47
Ono Pharma Enters Into Co-Development Agreement With BioFocus 48
EMD Millipore Enters Into Licensing Agreement With Charles River Labs For TrueSpike Technology 49
Charles River Labs to Invest USD10 Million in BioMotiv 50
Charles River Labs International Sells Preclinical Assets 51
ShangPharma Acquires Shanghai In-vivo Drug Research Facility From Charles River Labs 52
Charles River Laboratories Acquires Brains On-Line 53
Quotient Clinical Acquires QS Pharma from Charles River Labs 54
Charles River Laboratories Acquires Agilux Laboratories for USD64.9 Million 55
Charles River Labs Acquires Blue Stream Labs 56
Charles River Laboratories Acquires WIL Research for USD604.8 Million 57
Charles River Labs Acquires Oncotest 59
Charles River Labs Acquires ChanTest from Ampersand Capital for USD59.2 Million 60
Charles River Labs Completes Acquisition Of BioFocus And Argenta Discovery From Galapagos For USD191.8 Million 61
Charles River Labs Acquires Brass 63
Charles River Labs Completes Acquisition Of 75% Stake In Vital River Labs For US$27 Million 64
Charles River Plans Sale Of The Company 65
Charles River Laboratories International Inc, Key Competitors 66
Charles River Laboratories International Inc, Key Employees 67
Charles River Laboratories International Inc, Subsidiaries 69